The global “Polymerase Chain Reaction (PCR) ” Market is expected to reach USD 8.14 billion by 2026, on account of the advent of digitalization and the gradual shift from traditional PCR to digital PCR for diagnostics purposes. PCR is considered the most unique and most widely referred clinical testing technique utilized in modern biology. It includes a molecular technology for the in-vitro amplification of a specific region in a DNA strand.
More information on this market is presented in a recently published report by Fortune Business Insights™ titled, “Polymerase Chain Reaction (PCR) Market Size, Share & Industry Analysis, By Type (Standard PCR, Real-time PCR, and Digital PCR), By Product (Instruments and Reagents & Consumables), By Indication (Infectious Diseases, Oncology, Genetic Disorders, and Others), By End User (Hospitals & Clinics, Pharmaceutical & Biotechnology Industries, Diagnostic Centers, and Academic & Research Organizations), and Regional Forecast, 2019-2026.”
Request a Sample Copy of the Research Report:
What does the Report Include?
The market report includes quantitative and qualitative analysis of several factors such as the key drivers and restraints that will impact growth. Additionally, the report provides insights into the regional analysis that covers the different regions, which are contributing to the growth of the market. It includes the competitive landscape that involves leading companies and adoption of strategies by them to introduce new products, announce partnerships, and collaboration that will contribute to the growth of the market between 2020 and 2027. Moreover, the research analyst has adopted several research methodologies such as PESTEL and SWOT analysis to extract information about the current trends and industry developments that will drive the market growth in the forthcoming years.
An Overview of the Impact of COVID-19 on this Market:
The emergence of COVID-19 has brought the world to a standstill. We understand that this health crisis has brought an unprecedented impact on businesses across industries. However, this too shall pass. Rising support from governments and several companies can help in the fight against this highly contagious disease. There are some industries that are struggling and some are thriving. Overall, almost every sector is anticipated to be impacted by the pandemic.
We are taking continuous efforts to help your business sustain and grow during COVID-19 pandemics. Based on our experience and expertise, we will offer you an impact analysis of coronavirus outbreak across industries to help you prepare for the future.
For More Information in the Analysis of Reports:
https://www.fortunebusinessinsights.com/polymerase-chain-reaction-pcr-market-102528
Leading Players operating in the Polymerase Chain Reaction (PCR) Market are:
Key players are involved in mergers and acquisition to strengthen their market position. Owing to increasing competition frequent innovations are taking place in the market. Some of the companies operating the industry are:
- Agilent Technologies, Inc.,
- Qiagen
- Hoffmann-La Roche Ltd
- Bio-Rad Laboratories, Inc.
- Sysmex Inostics
- Abbott
- Thermo Fischer Scientific Inc.
- Eppendorf AG
- Other players
Government Initiatives for Increasing Awareness will Augment Growth
The increasing prevalence of infectious and genetic diseases is a significant factor in promoting the polymerase chain reaction market growth. Besides this, the rise in demand for innovative devices and the advent of miniature PCR devices are aiding in the expansion of the market. Moreover, the highly precise and direct quantification of digital PCRs is further anticipated to attract high PCR market revenue during the forecast period. However, the high cost associated with commercial PCR assays may pose a significant hindrance to the growth of the market.
